Mira Brekalo
Medical University of Vienna(AT)
Publications by Year
Research Areas
Heart Failure Treatment and Management, IL-33, ST2, and ILC Pathways, Atherosclerosis and Cardiovascular Diseases, Adipokines, Inflammation, and Metabolic Diseases, Immune cells in cancer
Most-Cited Works
- → Differential in vivo activation of monocyte subsets during low-grade inflammation through experimental endotoxemia in humans(2016)85 cited
- → A multi-biomarker risk score improves prediction of long-term mortality in patients with advanced heart failure(2012)70 cited
- → Predictive value of low interleukin-33 in critically ill patients(2017)30 cited
- → Innate Immune Training with Bacterial Extracts Enhances Lung Macrophage Recruitment to Protect from Betacoronavirus Infection(2021)30 cited
- → Reduced Monocyte and Neutrophil Infiltration and Activation by P-Selectin/CD62P Inhibition Enhances Thrombus Resolution in Mice(2024)28 cited
- → GDF‐15 is a better complimentary marker for risk stratification of arrhythmic death in non‐ischaemic, dilated cardiomyopathy than soluble ST2(2018)25 cited
- → Pharmacological inhibition of fatty acid oxidation reduces atherosclerosis progression by suppression of macrophage NLRP3 inflammasome activation(2021)25 cited
- → CD4+CD28null cells are an independent predictor of mortality in patients with heart failure(2013)24 cited
- → Effects of Nicorandil on Inflammation, Apoptosis and Atherosclerotic Plaque Progression(2021)21 cited
- → Neutrophil extracellular traps induce persistent lung tissue damage via thromboinflammation without altering virus resolution in a mouse coronavirus model(2023)17 cited